Recap: Conmed Q4 Earnings

Conmed CNMD reported its Q4 earnings results on Wednesday, January 26, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Conmed beat estimated earnings by 0.94%, reporting an EPS of $1.07 versus an estimate of $1.06, which did not surprise analysts.

Revenue was up $21.14 million from the same period last year.

Last quarter the company beat on EPS by $0.04, which was followed by a 4.27% increase in the share price the next day.

Here's a look at Conmed's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	0.76	0.62	0.44	0.76
EPS Actual	0.80	0.71	0.63	0.84
Revenue Estimate	255.53M	248.31M	216.88M	262.94M
Revenue Actual	248.83M	255.16M	232.68M	252.83M

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Conmed management provided guidance for their next quarter, expecting earnings between $3.6 and $3.85 per share for the next quarter.

This represents a 248.13% in quarter-over-quarter growth for Conmed, a bullish signal to many investors.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar